Matinas BioPharma Inc.
MTNB | AMEX
$1.51
-$0.39 (-20.53%)
At close: Oct 30, 2026, 3:59 PM ET
$1.19
-$0.32 (-21.19%)
Pre-market:
Nov 2, 2026, 6:02 AM ET
Market Data
Market Cap $644.89K
Enterprise Value $-110.11K
Beta 1.70
Average Volume 298.32K
Shares Outstanding (Diluted) 427.08K
Shares Change YoY 25.93%
Institutional Ownership 5.07%
Exchange AMEX
ISIN US5768104029
Price Performance
Price Change 1M -40.8%
Price Change 3M -65.8%
Price Change 6M -85.6%
Price Change YTD -82.8%
Price Change 1Y -92.7%
Price Change 3Y -99.1%
Price Change 5Y -99.8%
1M CAGR (ann.) -37.3%
1Y CAGR (ann.) -92.5%
5Y CAGR (ann.) -71.8%
All-Time CAGR -48.3%
Valuation
PE Ratio -0.08
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio N/A
Forward PS 0.00
PB Ratio 0.36
P/FCF Ratio -0.10
P/Adj. FCF Ratio -0.09
P/OCF Ratio -0.10
EV/Sales N/A
EV/EBIT 0.02
EV/EBITDA 0.02
EV/FCF 0.02
Earnings Yield -1202.0%
FCF Yield -995.5%
Adj. FCF Yield -1084.5%
Financial Health
Net Cash $761K
Total Debt $6K
Cash & Short-Term Investments $761K
Total Assets $3.41M
Current Ratio 0.85
Quick Ratio 0.85
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -1,070.00
Interest Coverage 0.00
Altman Z-Score -94.31
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -8.9%
Returns
Return on Assets -214.2%
Return on Equity -181.4%
Return on Invested Capital -323.2%
Return on Capital Employed -323.4%
Return on Tangible Assets -634.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -150.0%
Revenue CAGR 5Y -62.4%
Revenue CAGR 10Y -10.1%
EPS CAGR 3Y 56.9%
EPS CAGR 5Y 20.0%
EPS CAGR 10Y 11.1%
FCF CAGR 3Y 48.7%
FCF CAGR 5Y 23.0%
FCF CAGR 10Y 24.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$19.76
EPS Growth Est (next Q) 4840.6%
Revenue Est (next Q) $25K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-6.42M
Free Cash Flow $-6.42M
Adj. Free Cash Flow $-6.99M
FCF Per Share -$15.03
OCF Per Share -$15.03
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-107K
Operating Income $-6.67M
EBITDA $-6.27M
Net Income $-7.31M
EPS (Diluted) -$18.15
Revenue / Employee N/A
Profit / Employee $-3.65M
Employees 2
Add to Watchlist
Select watchlists to add or remove MTNB